
PF 03716556
CAS No. 928774-43-0
PF 03716556( —— )
Catalog No. M16652 CAS No. 928774-43-0
PF 3716556 is a potent and selective P-CAB (potassium-competitive acid blocker), with pIC50 of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 52 | In Stock |
![]() ![]() |
10MG | 85 | In Stock |
![]() ![]() |
25MG | 165 | In Stock |
![]() ![]() |
50MG | 322 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NamePF 03716556
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF 3716556 is a potent and selective P-CAB (potassium-competitive acid blocker), with pIC50 of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively.
-
DescriptionPF 3716556 is a potent and selective P-CAB (potassium-competitive acid blocker), with pIC50 of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively, inhibits gastric acid secretion, displays no activity at Na+,K+-ATPase, used for the treatment of gastroesophageal reflux disease.
-
In Vitro——
-
In VivoAnimal Model:Male Sprague-Dawley rats (250 -300 g) treated with Pentagastrin Dosage:1 mg/kg, 3 mg/kg, 10 mg/kg Administration:Intraduodenal administration; once Result:Inhibited gastric acid secretion in a dose-dependent manner.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetATPase
-
RecptorH+/K+-ATPase
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number928774-43-0
-
Formula Weight394.48
-
Molecular FormulaC22H26N4O3
-
Purity>98% (HPLC)
-
SolubilityEthanol: 79 mg/mL (200.26 mM); DMSO: 79 mg/mL (200.26 mM)
-
SMILESCC1=C2[C@@H](CCOC2=CC=C1)NC3=CC(=CN4C3=NC(=C4)C)C(=O)N(C)CCO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mori, et al. J Pharmacol Exp Ther. 2009 Feb;328(2):671-9.
molnova catalog



related products
-
Paederosidic acid me...
Paederosidic acid methyl ester has antinociception, is possibly related to the pathway of NO-cGMP-ATP sensitive K(+) channels.
-
Deslanoside
Deslanoside is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms. Deslanoside inhibits the Na-K-ATPase membrane pump resulting in an increase in intracellular sodium and calcium concentrations.
-
Digoxin
Digoxin is occasionally used in the treatment of various heart conditions namely atrial fibrillation atrial flutter and sometimes heart failure that cannot be controlled by other medication.